Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial-Reference-Cited by-同舟云学术

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

Published:2022-09-12 Issue:10 Volume:24 Page:1298-1309
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J of Clinical Hypertension

Author:

Sung Ki‐Chul¹^ORCID,Sung Jung Hoon²,Cho Eun Joo³,Ahn Jeong Cheon⁴,Han Seung Hwan⁵,Kim Weon⁶,Kim Kye Hun⁷,Sohn Il Suk⁸,Shin Jinho⁹^ORCID,Kim Seok Yeon¹⁰,Kim Kwang‐il¹¹,Kang Seok Min¹²,Park Sung‐Ji¹³,Kim Yong‐Jin¹⁴,Shin Joon‐Han¹⁵,Park Seong‐Mi¹⁶,Park Chang‐Gyu¹⁷^ORCID

Affiliation:

1. Division of Cardiology Department of Internal Medicine Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Korea

2. Division of Cardiology Bundang CHA Medical Center Sungnam Korea

3. Division of Cardiology Yeouido St. Mary's Hospital Catholic University Seoul Korea

4. Department of Cardiology Korea University Ansan Hospital Ansan Korea

5. Division of Cardiology Gachon University Gil Hospital Incheon Korea

6. Division of Cardiology and Internal Medicine Kyung Hee University Hospital Seoul Korea

7. Department of Cardiovascular Medicine Chonnam National University Medical School/Hospital KwangJu Korea

8. Department of Cardiology College of Medicine Kyung Hee University and Kyung Hee University Hospital at Gangdong Seoul Korea

9. Department of Internal Medicine Hanyang University Seoul Hospital Seoul Korea

10. Division of Cardiology Seoul Medical Center Seoul Korea

11. Department of Internal Medicine Seoul National University College of Medicine and Seoul National University Bundang Hospital Seoul Korea

12. Division of Cardiology Yonsei Cardiovascular Hospital Seoul Korea

13. Division of Cardiology Samsung Medical Center Seoul Korea

14. Division of Cardiology Seoul National University Hospital Seoul Korea

15. Department of Cardiology Ajou University Medical Center Suwon Korea

16. Division of Cardiology Korea University Anam Hospital Seoul Korea

17. Division of Cardiology Korea University Guro Hospital Seoul Korea

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.14570

Reference19 articles.

1. Prevalence of Cardiovascular Risk Factors in South Korean Adults: Results from the Korea Medical Insurance Corporation (KMIC) Study

2. Meta-analysis of hypertension as a risk factor of cerebrovascular disorders in Koreans

3. Prevention and Control of Hypertension

4. Clinical effectiveness and safety of amlodipine/losartan‐based single‐pill combination therapy in patients with hypertension: Findings from real‐world, multicenter observational databases

5. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Pill Combination Therapy of Amlodipine, Telmisartan, and Chlorthalidone in the Management of Hypertension: A Systematic Review of Randomized Controlled Trials;Cureus;2024-09-06

2. Posterior Shrinkage Towards Linear Subspaces;Bayesian Analysis;2024-01-01

3. Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis;PLOS ONE;2023-11-30

4. Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial;The Journal of Clinical Hypertension;2023-08-23

5. Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension;JAMA Cardiology;2023-06-01